Form D · Biotechnology
FirstVitals Inc.
Danville, CA · CIK 0002053118
Offering snapshot reported Apr 10, 2025 · SEC filing
- Reported sold
- $250K Offering amount: $250K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Mar 28, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 10, 2025 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-543313
Source: Form D, filed Apr 10, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ernest Lee | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2605 Camino Tassajara Unit 2500
Danville, CA, 94526
Danville, CA, 94526